Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
皮托布替尼治疗复发或难治性B细胞恶性肿瘤(BRUIN):一项1/2期研究
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(21)00224-5
Mato, Anthony R; Shah, Nirav N; Jurczak, Wojciech; Cheah, Chan Y; Pagel, John M; Woyach, Jennifer A; Fakhri, Bita; Eyre, Toby A; Lamanna, Nicole; Patel, Manish R; Alencar, Alvaro; Lech-Maranda, Ewa; Wierda, William G; Coombs, Catherine C; Gerson, James N; Ghia, Paolo; Le Gouill, Steven; Lewis, David John; Sundaram, Suchitra; Cohen, Jonathon B; Flinn, Ian W; Tam, Constantine S; Barve, Minal A; Kuss, Bryone; Taylor, Justin; Abdel-Wahab, Omar; Schuster, Stephen J; Palomba, M Lia; Lewis, Katharine L; Roeker, Lindsey E; Davids, Matthew S; Tan, Xuan Ni; Fenske, Timothy S; Wallin, Johan; Tsai, Donald E; Ku, Nora C; Zhu, Edward; Chen, Jessica; Yin, Ming; Nair, Binoj; Ebata, Kevin; Marella, Narasimha; Brown, Jennifer R; Wang, Michael